Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital

Annals of Pharmacotherapy

Volumn 42, Issue 10, 2008, Pages 1502-1506

  Miller, Melissa A ^a   Forni, Allison ^b   Yogaratnam, Dinesh ^b  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

^b Memorial Medical Center   (United States)

Author keywords

Lactic acidosis; Pentobarbital; Propylene glycol; Toxicity

Indexed keywords

ETIRACETAM; MIDAZOLAM; NORADRENALIN; PENTOBARBITAL; PHENYTOIN; PROPOFOL; PROPYLENE GLYCOL;

ADULT; ANION GAP; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG WITHDRAWAL; EPILEPTIC STATE; FEMALE; HUMAN; HYPOTENSION; LACTIC ACIDOSIS; LOADING DRUG DOSE; PRIORITY JOURNAL; SEDATION;

ACIDOSIS, LACTIC; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PENTOBARBITAL; PROPYLENE GLYCOL; STATUS EPILEPTICUS; VEHICLES;

EID: 52949083227     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L186     Document Type: Article

References (24)

1. Propylene glycol. POISINDEX System. Greenwood Village, CO: Thomson Micromedex, expires 2008 Dec 31 (accessed 2008 Feb 15).
2. Arroliga AC, Shehab N, McCarthy K, Gonzales JP. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med 2004;32:1709-14.
3. Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines. Chest 2005;128:1674-81.
4. Arbour RB. Propylene glycol toxicity related to high-dose lorazepam infusion: case report and discussion. Am J Crit Care 1999;8:499-506.
5. D'Ambrosio JA, Borchardt-Phelps P, Nolen JG, Cerra FB. Propylene glycol-induced lactic acidosis secondary to a continuous infusion lorazepam. (abstract 43). Pharmacotherapy 1993;13:274.
6. Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy 2001;21:1140-4.
7. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970-6.
8. Marik PE, Varon J. The management of status epilepticus. Chest 2004;126:582-91.
9. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43:146-53.
10. Robakis TK, Hirsch LJ. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 2006;4:35-46.
11. Naranjo CA, Shear NH, Lanctot KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol 1992;32:897-904.
12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
13. Yorgin PD, Theodorou AA, Al-Uzri A, Davenport K, Boyer-Hassen LV, Johnson MI. Propylene glycol-induced proximal renal tubular cell injury. Am J Kidney Dis 1997;30:134-9.
14. Food and Drug Administration. GRAS status of propylene glycol and propylene glycol monostearate. Fed Regist 1982;47:27810.
15. Martin G, Finberg L. Propylene glycol: a potentially toxic vehicle in liquid dosage form. J Pediatr 1970;77:877-9.
16. Christopher MM, Eckfeldt JH, Eaton JW. Propylene glycol ingestion causes D-lactic acidosis. Lab Invest 1990;62:114-8.
17. Neale BW, Mesler EL, Young M, Rebuck JA, Weise WJ. Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations. Ann Pharmacother 2005;39:1732-5. Epub 13 Sept 2005. DOI 10.1345/aph.1G083
18. Ruddick JA. Toxicology, metabolism and biochemistry of 12-propanediol. Toxicol Appl Pharmacol 1972;21:102-11.
19. Speth PA, Vree TB, Neilen NFM, et al. Propylene glycol pharmacokinetics and effects after intravenous infusion in humans. Ther Drug Monit 1987;9:255-8.
20. Product information. Nembutal (pentobarbital sodium). Lake Forest, IL: Ovation Pharmaceuticals Inc., April 2005.
21. Kang TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother 2002;36:1453-6. DOI 10.1345/aph.1A321
22. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003;29:1417-25.
23. Kanaumi T, Hirose S, Goto Y, Naitou E, Mitsudome A. An infant with mitochondrial A3243G mutation demonstrating MELAS phenotype. Pediatr Neurol 2006;34:235-8.
24. Minamoto H, Kawabata K, Okuda B, et al. Mitochondrial encephalomyopathy with elderly onset of stroke-like episodes. Intern Med 1996;35:991-5.